August 30, 2014 10:39 PM ET

Healthcare Providers and Services

Company Overview of 21st Century Oncology Holdings, Inc.

Company Overview

21st Century Oncology Holdings, Inc., together with its subsidiaries, operates as a physician-led provider of integrated cancer care services. Its radiation treatment services include external beam therapies, such as conformal radiation therapy, intensity modulated radiation therapy, and stereotactic radiosurgery, as well as internal radiation therapies, such as high-dose and low-dose rate brachytherapies. The company’s radiation treatment services also comprise image guided radiation therapy, Gamma function testing, and respiratory gating. In addition, it offers support services in the areas of psychological and nutritional counseling, as well as transportation assistance. Further, the comp...

2270 Colonial Boulevard

Fort Myers, FL 33907

United States

Founded in 1983

3,880 Employees

Phone:

239-931-7275

Key Executives for 21st Century Oncology Holdings, Inc.

Co-Founder
Age: 61
Vice Chairman
Age: 53
Chief Executive Officer of Medical Developers Cooperatief U A B V
Age: 55
Executive Vice President and General Counsel
Age: 62
Chief Accounting Officer
Age: 45
Compensation as of Fiscal Year 2014.

21st Century Oncology Holdings, Inc. Key Developments

21st Century Oncology Holdings, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

21st Century Oncology Holdings, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, total revenues were $265,898,000 against $178,109,000 a year ago. Loss before income taxes was $203,665,000 against $18,114,000 a year ago. Net loss attributable to the company’s shareholder was $207,524,000 against $20,139,000 a year ago. Total pro-forma revenues $265,898,000 against $190,838,000 a year ago. Pro-forma Adjusted EBITDA was $43,197,000 against $24,829,000 a year ago. For the quarter, total revenues were $499,295,000 against $352,086,000 a year ago. Loss before income taxes was $230,804,000 against $35,712,000 a year ago. Net loss attributable to the company’s shareholder $237,705,000 against $39,880,000 a year ago. Net cash provided by operating activities was $9,869,000 against $3,614,000 a year ago. Purchase of property and equipment was $33,147,000 against $17,769,000 a year ago. Total pro-forma revenues $508,114,000 against $380,271,000 a year ago. Pro-forma Adjusted EBITDA was $73,651,000 against $49,524,000 a year ago.

21st Century Oncology Holdings, Inc. to Report Q2, 2014 Results on Aug 20, 2014

21st Century Oncology Holdings, Inc. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Aug 20, 2014

21st Century Oncology Holdings, Inc., Q2 2014 Earnings Call, Aug 28, 2014

21st Century Oncology Holdings, Inc., Q2 2014 Earnings Call, Aug 28, 2014

Similar Private Companies By Industry

Company Name Region
Youville Place, Inc. United States
Ellipticare, LLC United States
Medop Acquisition, LLC United States
Consult A Doctor, Inc. United States
SeniorScript, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 15, 2014
Roger Williams Radiation Therapy, Llc
Merger/Acquisition
May 15, 2014
Southern New England Regional Cancer Center, LLC
Merger/Acquisition
May 1, 2014
Radiation Oncology Facility in Guatemala
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 21st Century Oncology Holdings, Inc., please visit www.rtsx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.